NCT03888846View on ClinicalTrials.gov

Topical Pentoxifylline Gel on Behcet's Disease Oral Ulcers

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

August 31, 2019

Study Completion Date

September 30, 2019

Conditions
Behçet Disease Affecting Oral Mucosa
Interventions
DRUG

Pentoxifylline

Topical gel version of pentoxifylline to be administered intraorally.

DRUG

Colchicine

Colchicine therapy is provided to patients with oral ulcers as part of supportive care routinely offered by Behcet's Clinic-Istanbul.

Trial Locations (1)

34098

Istanbul Universitesi-Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı-Romatoloji, Istanbul

All Listed Sponsors
collaborator

Istanbul University - Cerrahpasa

OTHER

lead

Ipekyolu Ilac Ltd. Sti

INDUSTRY

NCT03888846 - Topical Pentoxifylline Gel on Behcet's Disease Oral Ulcers | Biotech Hunter | Biotech Hunter